Inosan Biopharma General Manager Juan Lopez de Silanes outlines the Mexican family company’s recent milestones, including an impressive internationalisation push in the Middle East & Africa Region, how demand for antivenom products is evolving in emerging markets, and why knowledge transfer and inter-stakeholder collaboration is key for the firm’s future success.
We have developed different products for every region because snakes, scorpions and spiders are different in every place. Our vision is for no-one to suffer or die as a consequence of animal envenoming
